Wednesday, June 29, 2022
No Result
View All Result
Medical Finance
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
  • Home
  • News
  • Interviews
  • Mediknowledge
  • Insights From Industry
  • Thought Leaders
  • Coronavirus
  • Whitepapers
No Result
View All Result
Medical Finance
No Result
View All Result
Home News

Fortis Life Sciences acquires Abcore, a leader in nanobody technologies

by Medical Finance
in News
Scientists discover antibody that inhibits a broad range of sarbecoviruses
9
SHARES
103
VIEWS
Share on FacebookShare on Twitter

Fortis Life Sciences has acquired Abcore, a San Diego, California, USA based antibody discovery platform specializing in nanobody technology. With the addition of Abcore, Fortis extends its capabilities into the antibody discovery market serving biopharma customers developing antibody and nanobody-based therapeutics.

Abcore is a powerful addition to the Fortis portfolio and deepens our antibody product and service capabilities. We are particularly optimistic about the potential of nanobody technologies in therapeutic and diagnostic applications. Our acquisition of Abcore aligns perfectly with Fortis’ goal of partnering with and investing in world-class life sciences companies seeking a strategic growth partner.”


Brian Kim, Chief Executive Officer, Fortis, Remarked on the Partnership

“We are excited about accelerating Abcore’s growth as part of the Fortis family,” added David Barraclough, Chief Executive Officer of Abcore. “Fortis shares our commitment to scientific discovery, innovation, and customer service and is the ideal partner for Abcore as we expand our technical capabilities and bring new products and services to market.”

Our partnership with Fortis will provide Abcore with the commercial and operational infrastructure necessary for us to focus on developing high-quality products and better serving our customers.”


Jennifer Johnson, President of Abcore

Pivotal Scientific Ltd. acted as the exclusive corporate advisor to Abcore.

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Share 0
Medical Finance

Medical Finance

Related Posts

Bacterial biofilms use a developmental patterning mechanism seen in plants and animals

UMass Amherst assistant professor wins $1.4 million grant to engineer synthetic bacteria for water contaminant removal

by Medical Finance
June 29, 2022
0

Lauren Andrews, University of Massachusetts Amherst assistant professor and the Marvin and Eva Schlanger Faculty Fellow in the department of...

Why millions on Medicaid are at risk of losing coverage in the months ahead

Duke researchers identify role for key gene in developmental disability syndrome

by Medical Finance
June 29, 2022
0

A single gene that was previously found to be the driving force in a rare syndrome linked to epilepsy, autism...

PhoreMost and POLARISqb announce a multi-target collaboration to investigate next-generation cancer therapies

Scientists discover how to prevent T cell exhaustion to maintain the fight against cancer

by Medical Finance
June 28, 2022
0

When faced with a formidable foe for months on end, the immune system's T cells begin to tire. Whether fighting...

Cannabinoids may prevent infection with SARS-CoV-2, including variants

Cannabinoids may prevent infection with SARS-CoV-2, including variants

by Medical Finance
June 29, 2022
0

A new study published in the Journal of Natural Products of the American Chemical Society and American Society of Pharmacognosy...

Monitoring the presence of enteric pathogens in imported seafood

The Native Antigen Company Expands Range of Norovirus-Like Particles

by Medical Finance
June 28, 2022
0

The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into...

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

Ultra-rapid genome sequencing technology can detect rare genetic diseases in eight hours

by Medical Finance
June 28, 2022
0

A new ultra-rapid genome sequencing approach developed by Stanford Medicine scientists and their collaborators was used to diagnose rare genetic...

Next Post
Study: Prescribing Nirmatrelvir–Ritonavir: How to Recognize and Manage Drug–Drug Interactions. Image Credit: Artur Wnorowski/Shutterstock

Identifying and managing drug-drug interactions key to the safe use of nirmatrelvir–ritonavir in COVID-19 treatment

Study: Multiscale PHATE identifies multimodal signatures of COVID-19. Image Credit: Andrii Vodolazhskyi/Shutterstock

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

0 0 votes
Article Rating
Subscribe
Login
Notify of
guest
guest
0 Comments
Inline Feedbacks
View all comments

Support

  • Contact
  • Disclaimer
  • Home
  • Privacy Policy
  • Terms And Conditions

Categories

  • Coronavirus
  • Insights From Industry
  • Interviews
  • Mediknowledge
  • News
  • Thought Leaders
  • Whitepapers

More News

  • Accident Injury Information Report Health Rawpixel.com ac5524c1031e4229bc369a9a2a504d1c 620x480
    Covid precautions are part of Hispanic community’s efforts to tend to community good
  • bacteria Sebastian Kaulitzki 46826fb7971649bfaca04a9b4cef3309 620x480
    Covid aid to protect Montana prisons and jails sits unused
  • Home
  • Privacy Policy
  • Contact
  • Disclaimer
  • Terms And Conditions

© 2022 Medical Finance - Latest Financial and Business News

No Result
View All Result
  • Interviews
  • Mediknowledge
  • News
  • Insights From Industry
  • Coronavirus
  • Thought Leaders
  • Whitepapers
wpDiscuz
0
0
Would love your thoughts, please comment.x
()
x
| Reply